Skip to main content
Top
Published in: Journal of Ovarian Research 1/2019

Open Access 01-12-2019 | Endometrial Cancer | Research

Alteration of tumor associated neutrophils by PIK3CA expression in endometrial carcinoma from TCGA data

Authors: Yinglian Pan, Li Ping Jia, Yuzhu Liu, Yixu Han, Qingchun Deng

Published in: Journal of Ovarian Research | Issue 1/2019

Login to get access

Abstract

Uterine corpus endometrial carcinoma (UCEC) is one of the most common cancer in female worldwide. PIK3CA has been proven to be a strong prognostic biomarker in UCEC. Nevertheless, current studies have not investigated what effects PIK3CA had on tumor associated neutrophils (TANss). Kaplan-Meier methods were used to compute the survival time of TCGA UCEC patients. GO and KEGG enrichment analysis unveiled relevant pathways PIK3CA affected using DEGs between PIK3CA high expression group and PIK3CA low expression group in TCGA UCEC, as well as GSEA. immune infiltration status was calculated using TIMER. We found that PIK3CA influenced a number of pathways including immune related pathways. The fraction of TANs was certainly altered by PIK3CA expression in UCEC. Our findings suggest that PIK3CA expression may play an important role in tumor immune microenvironment and could alter fraction of TANs in UCEC.
Appendix
Available only for authorised users
Literature
1.
go back to reference Matteson KA, Robison K, Jacoby VL. Opportunities for early detection of endometrial Cancer in women with postmenopausal bleeding. JAMA Intern Med. 2018;178(9):1222–3.CrossRef Matteson KA, Robison K, Jacoby VL. Opportunities for early detection of endometrial Cancer in women with postmenopausal bleeding. JAMA Intern Med. 2018;178(9):1222–3.CrossRef
2.
go back to reference Jemal A, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.CrossRef Jemal A, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.CrossRef
3.
go back to reference Dedes KJ, et al. Emerging therapeutic targets in endometrial cancer. Nat Rev Clin Oncol. 2011;8(5):261–71.CrossRef Dedes KJ, et al. Emerging therapeutic targets in endometrial cancer. Nat Rev Clin Oncol. 2011;8(5):261–71.CrossRef
4.
go back to reference Malentacchi F, et al. Pilot investigation of the mutation profile of PIK3CA/PTEN genes (PI3K pathway) in grade 3 endometrial cancer. Oncol Rep. 2019;41(3):1560–74.PubMed Malentacchi F, et al. Pilot investigation of the mutation profile of PIK3CA/PTEN genes (PI3K pathway) in grade 3 endometrial cancer. Oncol Rep. 2019;41(3):1560–74.PubMed
5.
go back to reference Holst F, et al. PIK3CA amplification associates with aggressive phenotype but not markers of AKT-MTOR signaling in endometrial carcinoma. Clin Cancer Res. 2019;25(1):334–45.CrossRef Holst F, et al. PIK3CA amplification associates with aggressive phenotype but not markers of AKT-MTOR signaling in endometrial carcinoma. Clin Cancer Res. 2019;25(1):334–45.CrossRef
6.
go back to reference McIntyre JB, et al. PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma. Gynecol Oncol. 2014;132(1):188–93.CrossRef McIntyre JB, et al. PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma. Gynecol Oncol. 2014;132(1):188–93.CrossRef
7.
go back to reference Konopka B, et al. PIK3CA mutations and amplification in endometrioid endometrial carcinomas: relation to other genetic defects and clinicopathologic status of the tumors. Hum Pathol. 2011;42(11):1710–9.CrossRef Konopka B, et al. PIK3CA mutations and amplification in endometrioid endometrial carcinomas: relation to other genetic defects and clinicopathologic status of the tumors. Hum Pathol. 2011;42(11):1710–9.CrossRef
8.
go back to reference Kandoth C, et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497(7447):67–73.CrossRef Kandoth C, et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497(7447):67–73.CrossRef
9.
go back to reference Hurt B, et al. Cancer-promoting mechanisms of tumor-associated neutrophils. Am J Surg. 2017;214(5):938–44.CrossRef Hurt B, et al. Cancer-promoting mechanisms of tumor-associated neutrophils. Am J Surg. 2017;214(5):938–44.CrossRef
10.
go back to reference Kim J, Bae JS. Tumor-associated macrophages and neutrophils in tumor microenvironment. Mediat Inflamm. 2016;2016:6058147. Kim J, Bae JS. Tumor-associated macrophages and neutrophils in tumor microenvironment. Mediat Inflamm. 2016;2016:6058147.
11.
go back to reference Zhou SL, et al. Tumor-associated neutrophils recruit macrophages and T-regulatory cells to promote progression of hepatocellular carcinoma and resistance to Sorafenib. Gastroenterology. 2016;150(7):1646–1658.e17.CrossRef Zhou SL, et al. Tumor-associated neutrophils recruit macrophages and T-regulatory cells to promote progression of hepatocellular carcinoma and resistance to Sorafenib. Gastroenterology. 2016;150(7):1646–1658.e17.CrossRef
12.
go back to reference Gonzalez H, Hagerling C, Werb Z. Roles of the immune system in cancer: from tumor initiation to metastatic progression. Genes Dev. 2018;32(19–20):1267–84.CrossRef Gonzalez H, Hagerling C, Werb Z. Roles of the immune system in cancer: from tumor initiation to metastatic progression. Genes Dev. 2018;32(19–20):1267–84.CrossRef
13.
go back to reference Galdiero MR, et al. Occurrence and significance of tumor-associated neutrophils in patients with colorectal cancer. Int J Cancer. 2016;139(2):446–56.CrossRef Galdiero MR, et al. Occurrence and significance of tumor-associated neutrophils in patients with colorectal cancer. Int J Cancer. 2016;139(2):446–56.CrossRef
14.
go back to reference Giese MA, Hind LE, Huttenlocher A. Neutrophil plasticity in the tumor microenvironment. Blood. 2019;133(20):2159–67.CrossRef Giese MA, Hind LE, Huttenlocher A. Neutrophil plasticity in the tumor microenvironment. Blood. 2019;133(20):2159–67.CrossRef
15.
go back to reference Menyhart O, Nagy A, Gyorffy B. Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma. R Soc Open Sci. 2018;5(12):181006.CrossRef Menyhart O, Nagy A, Gyorffy B. Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma. R Soc Open Sci. 2018;5(12):181006.CrossRef
16.
go back to reference Gao J, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1.CrossRef Gao J, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1.CrossRef
17.
go back to reference Cerami E, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401–4.CrossRef Cerami E, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401–4.CrossRef
18.
19.
go back to reference Zhou C, et al. A systems biology-based approach to uncovering molecular mechanisms underlying effects of traditional Chinese medicine Qingdai in chronic myelogenous leukemia, involving integration of network pharmacology and molecular docking technology. Med Sci Monit. 2018;24:4305–16.CrossRef Zhou C, et al. A systems biology-based approach to uncovering molecular mechanisms underlying effects of traditional Chinese medicine Qingdai in chronic myelogenous leukemia, involving integration of network pharmacology and molecular docking technology. Med Sci Monit. 2018;24:4305–16.CrossRef
20.
go back to reference Christensen E, et al. Liquid biopsy analysis of FGFR3 and PIK3CA hotspot mutations for disease surveillance in bladder Cancer. Eur Urol. 2017;71(6):961–9.CrossRef Christensen E, et al. Liquid biopsy analysis of FGFR3 and PIK3CA hotspot mutations for disease surveillance in bladder Cancer. Eur Urol. 2017;71(6):961–9.CrossRef
21.
go back to reference Yang L, Pang Y, Moses HL. TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression. Trends Immunol. 2010;31(6):220–7.CrossRef Yang L, Pang Y, Moses HL. TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression. Trends Immunol. 2010;31(6):220–7.CrossRef
22.
go back to reference Shull AY, et al. Novel somatic mutations to PI3K pathway genes in metastatic melanoma. PLoS One. 2012;7(8):e43369.CrossRef Shull AY, et al. Novel somatic mutations to PI3K pathway genes in metastatic melanoma. PLoS One. 2012;7(8):e43369.CrossRef
23.
go back to reference Huang J, et al. Frequent genetic abnormalities of the PI3K/AKT pathway in primary ovarian cancer predict patient outcome. Genes Chromosomes Cancer. 2011;50(8):606–18.CrossRef Huang J, et al. Frequent genetic abnormalities of the PI3K/AKT pathway in primary ovarian cancer predict patient outcome. Genes Chromosomes Cancer. 2011;50(8):606–18.CrossRef
24.
go back to reference Hung PF, et al. Hypoxia-induced slug SUMOylation enhances lung cancer metastasis. J Exp Clin Cancer Res. 2019;38:5.CrossRef Hung PF, et al. Hypoxia-induced slug SUMOylation enhances lung cancer metastasis. J Exp Clin Cancer Res. 2019;38:5.CrossRef
25.
go back to reference Heo KS. Regulation of post-translational modification in breast cancer treatment. BMB Rep. 2019;52(2):113–8.CrossRef Heo KS. Regulation of post-translational modification in breast cancer treatment. BMB Rep. 2019;52(2):113–8.CrossRef
26.
go back to reference Goncalves J, et al. TBCCD1, a new centrosomal protein, is required for centrosome and Golgi apparatus positioning. EMBO Rep. 2010;11(3):194–200.CrossRef Goncalves J, et al. TBCCD1, a new centrosomal protein, is required for centrosome and Golgi apparatus positioning. EMBO Rep. 2010;11(3):194–200.CrossRef
Metadata
Title
Alteration of tumor associated neutrophils by PIK3CA expression in endometrial carcinoma from TCGA data
Authors
Yinglian Pan
Li Ping Jia
Yuzhu Liu
Yixu Han
Qingchun Deng
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Journal of Ovarian Research / Issue 1/2019
Electronic ISSN: 1757-2215
DOI
https://doi.org/10.1186/s13048-019-0557-6

Other articles of this Issue 1/2019

Journal of Ovarian Research 1/2019 Go to the issue